Cargando…

The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia

INTRODUCTION: Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objec...

Descripción completa

Detalles Bibliográficos
Autores principales: De Broucker, Gatien, Salvatore, Phillip P., Mutembo, Simon, Moyo, Nkumbula, Mutanga, Jane N., Thuma, Philip E., Moss, William J., Sutcliffe, Catherine G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943017/
https://www.ncbi.nlm.nih.gov/pubmed/33690733
http://dx.doi.org/10.1371/journal.pone.0248217
_version_ 1783662415157657600
author De Broucker, Gatien
Salvatore, Phillip P.
Mutembo, Simon
Moyo, Nkumbula
Mutanga, Jane N.
Thuma, Philip E.
Moss, William J.
Sutcliffe, Catherine G.
author_facet De Broucker, Gatien
Salvatore, Phillip P.
Mutembo, Simon
Moyo, Nkumbula
Mutanga, Jane N.
Thuma, Philip E.
Moss, William J.
Sutcliffe, Catherine G.
author_sort De Broucker, Gatien
collection PubMed
description INTRODUCTION: Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objective of this study was to determine the cost-effectiveness of PoC testing in Southern Province, Zambia. METHODS: A decision tree model was developed to compare health outcomes and costs between the standard of care (SoC) and PoC testing using GeneXpert and m-PIMA platforms. The primary health outcome was antiretroviral treatment (ART) initiation within 60 days of sample collection. Additional outcomes included ART initiation by 12 months of age and death prior to ART initiation. Costs included both capital and recurrent costs. Health outcomes and costs were combined to create incremental cost effectiveness ratios (ICERs). RESULTS: The proportion of children initiating ART within 60 days increased from 27.8% with SoC to 79.8–82.8% with PoC testing depending on the algorithm and platform. The proportion of children initiating ART by 12 months of age increased from 50.9% with SoC to 84.0–86.5% with PoC testing. The proportion of HIV-infected children dying prior to ART initiation decreased from 18.1% with SoC to 3.8–4.6% with PoC testing. Total program costs were similar for the SoC and GeneXpert but higher for m-PIMA. ICERs for PoC testing were favorable, ranging from $23–1,609 for ART initiation within 60 days, $37–2,491 for ART initiation by 12 months of age, and $90–6,188 for deaths prior to ART initiation. Factors impacting the costs of PoC testing, including the lifespan of the testing instruments and integrated utilization of PoC platforms, had the biggest impact on the ICERs. Integrating utilization across programs decreased costs for the EID program, such that PoC testing was cost-saving in some situations. CONCLUSION: PoC testing has the potential to improve linkage to care and ART initiation for HIV-infected infants and should be considered for implementation within EID programs to achieve equity in access to HIV services and reduce HIV-related pediatric morbidity and mortality.
format Online
Article
Text
id pubmed-7943017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79430172021-03-19 The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia De Broucker, Gatien Salvatore, Phillip P. Mutembo, Simon Moyo, Nkumbula Mutanga, Jane N. Thuma, Philip E. Moss, William J. Sutcliffe, Catherine G. PLoS One Research Article INTRODUCTION: Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objective of this study was to determine the cost-effectiveness of PoC testing in Southern Province, Zambia. METHODS: A decision tree model was developed to compare health outcomes and costs between the standard of care (SoC) and PoC testing using GeneXpert and m-PIMA platforms. The primary health outcome was antiretroviral treatment (ART) initiation within 60 days of sample collection. Additional outcomes included ART initiation by 12 months of age and death prior to ART initiation. Costs included both capital and recurrent costs. Health outcomes and costs were combined to create incremental cost effectiveness ratios (ICERs). RESULTS: The proportion of children initiating ART within 60 days increased from 27.8% with SoC to 79.8–82.8% with PoC testing depending on the algorithm and platform. The proportion of children initiating ART by 12 months of age increased from 50.9% with SoC to 84.0–86.5% with PoC testing. The proportion of HIV-infected children dying prior to ART initiation decreased from 18.1% with SoC to 3.8–4.6% with PoC testing. Total program costs were similar for the SoC and GeneXpert but higher for m-PIMA. ICERs for PoC testing were favorable, ranging from $23–1,609 for ART initiation within 60 days, $37–2,491 for ART initiation by 12 months of age, and $90–6,188 for deaths prior to ART initiation. Factors impacting the costs of PoC testing, including the lifespan of the testing instruments and integrated utilization of PoC platforms, had the biggest impact on the ICERs. Integrating utilization across programs decreased costs for the EID program, such that PoC testing was cost-saving in some situations. CONCLUSION: PoC testing has the potential to improve linkage to care and ART initiation for HIV-infected infants and should be considered for implementation within EID programs to achieve equity in access to HIV services and reduce HIV-related pediatric morbidity and mortality. Public Library of Science 2021-03-09 /pmc/articles/PMC7943017/ /pubmed/33690733 http://dx.doi.org/10.1371/journal.pone.0248217 Text en © 2021 De Broucker et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
De Broucker, Gatien
Salvatore, Phillip P.
Mutembo, Simon
Moyo, Nkumbula
Mutanga, Jane N.
Thuma, Philip E.
Moss, William J.
Sutcliffe, Catherine G.
The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
title The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
title_full The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
title_fullStr The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
title_full_unstemmed The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
title_short The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia
title_sort cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of hiv in southern zambia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943017/
https://www.ncbi.nlm.nih.gov/pubmed/33690733
http://dx.doi.org/10.1371/journal.pone.0248217
work_keys_str_mv AT debrouckergatien thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT salvatorephillipp thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT mutembosimon thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT moyonkumbula thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT mutangajanen thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT thumaphilipe thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT mosswilliamj thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT sutcliffecatherineg thecosteffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT debrouckergatien costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT salvatorephillipp costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT mutembosimon costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT moyonkumbula costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT mutangajanen costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT thumaphilipe costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT mosswilliamj costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia
AT sutcliffecatherineg costeffectivenessofscalinguprapidpointofcaretestingforearlyinfantdiagnosisofhivinsouthernzambia